Genome-Based Medicine for Acute Myeloid Leukemia: Study and Targeting of Molecular Alterations and Use of Minimal Residual Disease as a Biomarker

Acute myeloid leukemia (AML) is a highly heterogeneous hematologic malignancy characterized by the clonal proliferation of hematopoietic stem and progenitor cells (HSPCs) and blockade of differentiation and proliferation of immature myeloid cells that accumulate in bone marrow at the expense of norm...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Ugo Testa, Germana Castelli, Elvira Pelosi
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2022-09-01
Rangatū:	Hemato
Ngā marau:	acute myeloid leukemia genomics next generation sequencing minimal residual disease chemotherapy stem cell transplantation
Urunga tuihono:	https://www.mdpi.com/2673-6357/3/3/38
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!